BIO-IMPLANT MARKET ANALYSIS

Bio-implant Market, By Product Type (Cardiovascular Implants, Dental Implants, Spinal Bio-implants, Orthopedic Implants, Ophthalmic Implants, and Others), By Material Type (Biomaterial Metal, Ceramic, Alloys, and Polymer), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : May 2023
Code : CMI3050
Pages :178
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

Global Bio-implant Market- Regional Analysis

Among region, North America is expected to dominate the global bio-implant market over the forecast period, owing to North America 35.10% market share. High prevalence of cardiovascular diseases such as coronary heart disease, ischemic heart disease, arrhythmias, and others is expected to drive North America bio-implant market growth. For instance, according to an article published by Circulation Journal, a peer reviewed open access journal, in January 2021, the prevalence of cardiovascular diseases in adults above age of 20 years, in U.S., is around 49.2% (126.9 million in 2018), and increases with age in both males and females. The same source stated that the incidence of valvular heart disease is around 64 per 100, 000 person-years, with aortic stenosis (47.2%), mitral regurgitation (24.2%), and aortic regurgitation (18.0%) contributing most of the valvular diagnoses in 2018, in U.S.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa